Short Title:
CVD CM Combined Effects to SCLT/HMTA
Responsible HRP Element:
Human Health Countermeasures
Funding Status:
Planned-Funded - Task expected to be within budget
|
Procurement Mechanism(s):
|
|
Aims:
The maturation task will
(1) review the findings of the Lunar and Deep Space Gateway CVD countermeasure study;
(2) develop a prescription that will be used on Mars and deep space missions; and
(3) present the findings at boards to transition to appropriate operations stakeholders, as required
Category:
Countermeasure
Subcategory:
Clinical Procedure/Prescription
Deliverable Title:
CVD CM Combined Effects to SCLT/HMTA
Description:
Requirements for CVD countermeasures that have been validated on Gateway and the moon will be delivered to HMTA. CM requirements will be fully validated for weightlessness and deep-space radiation levels.
Internal Customers:
None
External Customers:
Health & Medical Technical Authority (HMTA)
System Capability Leadership Team (SCLT)
Is a Customer-Supplier Agreement (CSA) Required?
No
Maturation Deliverable:
Countermeasure
Primary Crew Health & Performance System Impact:
Medical
Secondary Crew Health & Performance System Impacts:
None
Mission:
Lunar Habitat
Technology & Countermeasure Readiness Level (TRL/CRL):
TBD (to be determined)